摘要
目的:分析芪胶升白胶囊治疗肺癌化疗引起的白细胞减少症的效果。方法:选取2022年5月—2023年5月西安交通大学第二附属医院收治的肺癌化疗引起的白细胞减少症患者80例作为研究对象,按照随机数字表法分为对照组和观察组,各40例。对照组给予地榆升白片治疗,观察组给予芪胶升白胶囊治疗。比较两组治疗效果。结果:治疗1、8周后,两组白细胞计数逐渐升高,且治疗8周后观察组白细胞计数高于对照组(P<0.05)。治疗后,两组生活质量评分高于治疗前,且观察组高于对照组,差异有统计学意义(P<0.05)。观察组治疗总有效率高于对照组,差异有统计学意义(P=0.003)。观察组不良反应总发生率低于对照组,差异有统计学意义(P=0.034)。结论:芪胶升白胶囊治疗肺癌化疗引起的白细胞减少症的效果显著,可提高白细胞水平,改善生活质量,降低不良反应发生率。
Objective:To analyze the effect of Qijiao Shengbai Capsule in treatment of leukopenia induced by chemotherapy for lung cancer.Methods:From May 2022 to May 2023,80 patients with leukopenia induced by chemotherapy for lung cancer who were admitted to the Second Affiliated Hospital of Xi'an Jiaotong University were selected as the study subjects.They were divided into control group and observation group according to random number table method,with 40 cases in each group.The control group was treated with Diyu Shengbai Tablets and the observation group was treated with Qijiao Shengbai Capsule.The treatment effects were compared between the two groups.Results:After 1 week and 8 weeks of treatment,the white blood cell count in the two groups gradually increased,and the white blood cell count in the observation group was higher than that in the control group after 8 weeks of treatment(P<0.05).After treatment,the quality of life scores in the two groups were higher than those before treatment,and the scores in the observation group were higher than those in the control group,with a statistically significant difference(P<0.05).The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P=0.003).The total incidence of adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(P=0.034).Conclusion:Qijiao Shengbai Capsule has significant effects in treatment of leukopenia induced by chemotherapy for lung cancer,and can increase white blood cell level,improve quality of life,and reduce the incidence of adverse reactions.
作者
任宏涛
李心乐
Ren Hongtao;Li Xinle(The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710004,Shaanxi Province,China)
出处
《中国社区医师》
2024年第31期59-61,共3页
Chinese Community Doctors
关键词
芪胶升白胶囊
肺癌
化疗
白细胞减少症
Qijiao Shengbai Capsule
Lung cancer
Chemotherapy
Leukopenia